# S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

> **NCT00265785** · PHASE2 · TERMINATED · sponsor: **SWOG Cancer Research Network** · enrollment: 27 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** pemetrexed

## Key facts

- **NCT ID:** NCT00265785
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-07
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** Closed due to poor accrual
- **Last updated:** 2012-11-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00265785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00265785, "S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00265785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*